trending Market Intelligence /marketintelligence/en/news-insights/trending/absiLqdVRC_HiWP4NqZeBw2 content esgSubNav
In This List

Milestone Scientific evaluating strategic options, including potential sale

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


Milestone Scientific evaluating strategic options, including potential sale

Milestone Scientific Inc. said its board plans to set up a special committee to explore strategic options, including a potential sale of the company.

The Livingston, N.J.-based medical device company said the strategic options may also include licensing of different instruments or other business combinations.

Milestone Scientific is developing the DPS dynamic pressure sensing technology that is designed to make injections precise, efficient and virtually painless.

Taking into account the third-party interest in the technology, including both dental and medical applications, the board decided to evaluate all potential strategic options, said Milestone Scientific Chairman Leslie Bernhard.